Development of a new fear of hypoglycemia scale: preliminary results

Jodi L Kamps1, Michael C Roberts, R Enrique Varela

  • 1Children's Hospital of New Orleans, Department of Psychology, New Orleans, Louisiana 70118, USA. jkamps21@yahoo.com

Insights

The Children's Hypoglycemia Index (CHI) reliably measures fear of hypoglycemia (FH) in children with type 1 diabetes. This new scale shows validity and has clinical and research applications for pediatric diabetes care.

Area of Science:

  • Pediatric Endocrinology
  • Psychometrics
  • Diabetes Management

Background:

  • Fear of hypoglycemia (FH) is a significant concern for children with type 1 diabetes.
  • Accurate measurement of FH is crucial for effective management and improved quality of life.
  • Existing measures may not fully capture the nuances of FH in pediatric populations.

Purpose of the Study:

  • To introduce and provide preliminary psychometric data for the Children's Hypoglycemia Index (CHI).
  • To establish the reliability and validity of the CHI as a tool for assessing FH in children.
  • To explore the relationship between past severe hypoglycemia and current fear levels.

Main Methods:

  • 109 children with type 1 diabetes completed the CHI, with 57 re-tested after 2 weeks.
  • Participants also completed the Children's Hypoglycemia Fear Survey (CHFS) and Revised Children's Manifest Anxiety Scale (RCMAS).
  • Hypoglycemia history was collected from both children and parents.

Main Results:

  • The CHI exhibited strong factor structure, internal consistency, and test-retest reliability.
  • Criterion-related validity was confirmed through comparison with established measures.
  • History of severe hypoglycemia predicted scores on specific CHI subscales.

Conclusions:

  • The CHI is a reliable and valid instrument for measuring fear of hypoglycemia in children.
  • This new scale offers significant clinical and research utility in pediatric diabetes care.
  • The CHI can aid in identifying children needing targeted interventions for hypoglycemia fear.
Abstract

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Preparedness and Phobias01:09

Preparedness and Phobias

Human fear responses to certain stimuli, such as darkness, heights, deep water, and blood, can often arise despite the absence of direct negative experiences. This phenomenon is rooted in evolutionary psychology, which posits that humans have developed a predisposition to fear stimuli that historically posed significant survival threats. This predisposition, known as preparedness, suggests that early humans who developed a fear of potentially dangerous entities, such as venomous snakes and...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...